‹ All Posts
Mayank Kumar

20th May 2025 · SEBI-Registered Analyst

Sun Pharma

SPARC
Sun Pharma: US FDA approves company’s next generation BLU-U blue light photodynamic therapy (PDT) for actinic keratosis (Positive) 1550-1500 is a important support zone in sunpharma.

#FundamentalViews#TechnicalViews
SUNPHARMA_2025-05-20_06-45-48.png
125 likes·55 comments